Next Article in Journal
U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study
Previous Article in Journal
Do not Lose Your Students in Large Lectures: A Five-Step Paper-Based Model to Foster Students’ Participation
Article Menu

Export Article

Open AccessProject Report
Pharmacy 2015, 3(3), 101-128;

A European Competence Framework for Industrial Pharmacy Practice in Biotechnology

Pharmacolor Consultants Nancy (pcn-consultants), 12 rue de Versigny, 54600 Villers, France
Callum Consultancy, 571 Berwyn Baptist Road, Devon, PA 19333, USA
Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium
Department of Pharmacy, Waterloo Campus, King's College London, 150 Stamford Street SE1, 9NH, London, UK
European Association of Faculties of Pharmacy (EAFP), Department Pharmaceutical Sciences, Utrecht University, PO Box 80082, 3508 TB Utrecht, The Netherlands
European Federation of Pharmaceutical Industries and Associations (EFPIA), Rue du Trône, 108, 1050 Brussels, Belgium
European Industrial Pharmacists' Group (EIPG), 4 avenue Ruysdael, Paris, France
Genzyme Flanders, Cipalstraat 8, 2440 Geel, Belgium
Pharmacy Department, Universitá di Catania, Viale Andrea Doria 6, 95125, Catania, Italy
Areta International, via Roberto LePetit, 21040 Gerenzano, Italy
Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium
Life and Health Sciences, Aston University, Aston Triangle, B75 6D9 Birmingham, UK
Author to whom correspondence should be addressed.
Academic Editor: Maree Donna Simpson
Received: 6 March 2015 / Revised: 24 June 2015 / Accepted: 22 July 2015 / Published: 29 July 2015
Full-Text   |   PDF [4728 KB, uploaded 29 July 2015]


The PHAR-IN (“Competences for industrial pharmacy practice in biotechnology”) looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: “Research and Development”, ‘“Upstream” and “Downstream” Processing’, “Product development and formulation”, “Aseptic processing”, “Analytical methodology”, “Product stability”, and “Regulation”. The main area of disagreement was in the category “Ethics and drug safety” where academics ranked competences higher than did industrial employees. View Full-Text
Keywords: education; pharmacy; industry; Europe; biotechnology education; pharmacy; industry; Europe; biotechnology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Atkinson, J.; Crowley, P.; De Paepe, K.; Gennery, B.; Koster, A.; Martini, L.; Moffat, V.; Nicholson, J.; Pauwels, G.; Ronsisvalle, G.; Sousa, V.; van Schravendijk, C.; Wilson, K. A European Competence Framework for Industrial Pharmacy Practice in Biotechnology. Pharmacy 2015, 3, 101-128.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top